Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1110P designates a **pseudogene** corresponding to the U6 small nuclear RNA (snRNA). U6 snRNAs are non-coding RNAs essential for pre-mRNA splicing, functioning as integral components of the spliceosome; however, pseudogenes such as RNU6-1110P are non-functional genomic loci that bear sequence similarity to bona fide U6 snRNA genes but are not transcribed into active, functional RNA[3][4][5]. Pseudogenes can arise by retrotransposition, gene duplication, or genomic rearrangements, and in the case of U6 snRNA, large numbers of these pseudogenes are found in the human and other vertebrate genomes, providing a record of retrotransposition events but no known regulatory or structural function[4][5]. **Key clarifications:** - The primary functional unit is the U6 small nuclear RNA, involved in splicing[1][3]. However, all evidence indicates that RNU6-1110P is a processed pseudogene, not transcribed into functional RNA, nor associated with protein products, druggability, or human disease[4][5]. - No evidence supports classification as a receptor, enzyme, transporter, or any other canonical drug target. - Thus, it is not a therapeutic target nor should it be included among functionally active molecular targets. If you need information on *functional* U6 snRNA, which is vital for spliceosome activity, or on other spliceosomal components, please clarify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1110, pseudogene (RNU6-1110P).